Movement Alert｜Pfizer Rises 3.08% in Regular Trading, Pharma Sector Broadly Lifted by GlaxoSmithKline Strong Q2 Earnings

Market Focus

Jul 28

On July 28, Pfizer rose 3.08% in regular trading, trading at $25.375/share, with turnover of $369 million. The rally was driven by a broad pharma sector uplift following GlaxoSmithKline's better-than-expected second-quarter earnings report.

GlaxoSmithKline reported adjusted earnings per share of 50.5 pence, significantly exceeding the market consensus estimate of 46.8 pence. The company also announced plans to fully achieve annual cost savings of GBP 1.9 billion by 2029, further boosting investor confidence in sector-wide profitability. The strong results triggered a rally across major pharmaceutical names, with GlaxoSmithKline up 5.62%, Merck up 2.82%, Eli Lilly up 2.53%, Johnson & Johnson up 2.45%, and AstraZeneca up 2.15%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1125024974"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1125024974\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1125024974?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-28 22:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1125024974","market":"us","top_or_hot":-1,"title":"Movement Alert｜Pfizer Rises 3.08% in Regular Trading, Pharma Sector Broadly Lifted by GlaxoSmithKline Strong Q2 Earnings","media":"Market Focus","content":"<p><p>On July 28, Pfizer rose 3.08% in regular trading, trading at $25.375/share, with turnover of $369 million. The rally was driven by a broad pharma sector uplift following GlaxoSmithKline's better-than-expected second-quarter earnings report.</p><p>GlaxoSmithKline reported adjusted earnings per share of 50.5 pence, significantly exceeding the market consensus estimate of 46.8 pence. The company also announced plans to fully achieve annual cost savings of GBP 1.9 billion by 2029, further boosting investor confidence in sector-wide profitability. The strong results triggered a rally across major pharmaceutical names, with GlaxoSmithKline up 5.62%, Merck up 2.82%, Eli Lilly up 2.53%, Johnson & Johnson up 2.45%, and AstraZeneca up 2.15%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Pfizer Rises 3.08% in Regular Trading, Pharma Sector Broadly Lifted by GlaxoSmithKline Strong Q2 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Pfizer Rises 3.08% in Regular Trading, Pharma Sector Broadly Lifted by GlaxoSmithKline Strong Q2 Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-28 22:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 28, Pfizer rose 3.08% in regular trading, trading at $25.375/share, with turnover of $369 million. The rally was driven by a broad pharma sector uplift following GlaxoSmithKline's better-than-expected second-quarter earnings report.</p><p>GlaxoSmithKline reported adjusted earnings per share of 50.5 pence, significantly exceeding the market consensus estimate of 46.8 pence. The company also announced plans to fully achieve annual cost savings of GBP 1.9 billion by 2029, further boosting investor confidence in sector-wide profitability. The strong results triggered a rally across major pharmaceutical names, with GlaxoSmithKline up 5.62%, Merck up 2.82%, Eli Lilly up 2.53%, Johnson & Johnson up 2.45%, and AstraZeneca up 2.15%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PFE","symbol_name":"辉瑞","start_time":0,"source_url":"","article_id":"1125024974","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1125024974","pubTimestamp":1785249625,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 28, Pfizer rose 3.08% in regular trading, trading at $25.375/share, with turnover of $369 million. The rally was driven by a broad pharma sector uplift following GlaxoSmithKline's...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PFE":"辉瑞"},"translate_title":"走势提醒|辉瑞常规交易中上涨 3.08%，葛兰素史克强劲第二季度盈利提振制药板块普遍上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFE":1},"content_text":"On July 28, Pfizer rose 3.08% in regular trading, trading at $25.375/share, with turnover of $369 million. The rally was driven by a broad pharma sector uplift following GlaxoSmithKline's better-than-expected second-quarter earnings report.GlaxoSmithKline reported adjusted earnings per share of 50.5 pence, significantly exceeding the market consensus estimate of 46.8 pence. The company also announced plans to fully achieve annual cost savings of GBP 1.9 billion by 2029, further boosting investor confidence in sector-wide profitability. The strong results triggered a rally across major pharmaceutical names, with GlaxoSmithKline up 5.62%, Merck up 2.82%, Eli Lilly up 2.53%, Johnson & Johnson up 2.45%, and AstraZeneca up 2.15%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}